DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

PEG-Intron (Peginterferon Alfa-2B) - Side Effect Reports to FDA

 
 



Index of reports > All Cases (1729)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) all cases. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 1729   Next >>

Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: White Blood Cell Count Decreased, Renal Impairment, Anaemia, Platelet Count Decreased, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 mcg /kg/week
    Indication: Hepatitis C
    Start date: 2012-04-13
    End date: 2012-04-25

PEG-Intron
    Dosage: 1.0 mcg /kg/week
    Start date: 2012-06-26

PEG-Intron
    Dosage: 1.0 mcg /kg/week
    Start date: 2012-04-26
    End date: 2012-06-06

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-13
    End date: 2012-06-06

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-06-26

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-13
    End date: 2012-06-07

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-06-26
    End date: 2012-07-24

Other drugs received by patient: Motilium; Lorfenamin; Motilium; L Cartin; Rikkunshi-TO; Epadel



Possible PEG-Intron side effects in 59 year old female

Reported by a physician from Canada on 2012-08-27

Patient: 59 year old female, weighing 44.0 kg (96.8 pounds)

Reactions: Oesophageal Varices Haemorrhage, Ascites

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Incivek
    Dosage: 750 mg, tid
    Administration route: Oral
    Indication: Hepatitis C

PEG-Intron
    Dosage: 120 unk, unk
    Indication: Hepatitis C

Other drugs received by patient: Nadolol; Lasix; Atenolol; Spironolactone; Eprex



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient:

Reactions: Irritability, Fatigue

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 ?g, qw
    Indication: Hepatitis C
    Start date: 2012-05-16

Ribavirin
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Orgasuline Rapide; Antiviral (Unspecified)



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Nausea

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 80 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-06-12
    End date: 2012-06-17

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-12
    End date: 2012-06-17

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-12
    End date: 2012-06-17

Other drugs received by patient: Talion (Bepotastine Besylate); Mucosta; Loxonin



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-27

Patient:

Reactions: Product Quality Issue, NO Adverse Event, Underdose

Drug(s) suspected as cause:
PEG-Intron



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-27

Patient:

Reactions: Product Quality Issue, Abdominal Discomfort, Malaise, Pneumonia, Nasopharyngitis, Vomiting, Bronchitis, Cough

Drug(s) suspected as cause:
PEG-Intron

Other drugs received by patient: Lisinopril; Seroquel



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: Anaemia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 0.8 microgram per kilogram, qw
    Start date: 2012-05-08

PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-04-24

PEG-Intron
    Dosage: 1.0 microgram per kilogram, qw
    Start date: 2012-05-01
    End date: 2012-05-01

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-18

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-07-12

Other drugs received by patient: Claritin; Ferotym; Livalo; Epadel S



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient:

Reactions: Haemoglobin Decreased, Dysgeusia, Nausea, Chills, Asthenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 80 microgram, qw

Rebetol
    Dosage: unk
    Administration route: Oral

Victrelis
    Dosage: unk
    Administration route: Oral

Other drugs received by patient: Protonix



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Generalised Erythema

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, unk
    Indication: Hepatitis C

Rebetol
    Dosage: 800 mg, unk
    Administration route: Oral
    Start date: 2012-05-08
    End date: 2012-05-14

Rebetol
    Dosage: 400 mg, unk
    Administration route: Oral
    Start date: 2012-05-15

Rebetol
    Dosage: 1000 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-24
    End date: 2012-05-07

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-07-03
    End date: 2012-07-05

Telavic
    Dosage: 2250 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-24
    End date: 2012-06-11

Other drugs received by patient: Norvasc; Rinderon V; Allopurinol; Hirudoid; Xyzal; Allopurinol; Prednisolone; Rabeprazole Sodium; Rabeprazole Sodium; [composition Unspecified]; Clobetasol Propionate; Sitagliptin Phosphate



Possible PEG-Intron side effects in

Reported by a individual with unspecified qualification from Germany on 2012-08-27

Patient:

Reactions: Maternal Exposure Before Pregnancy, Abortion Induced

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis
    End date: 2012-01-01

Rebetol
    Dosage: unk
    End date: 2012-01-01

Victrelis
    Dosage: 200 mg, qd
    Indication: Hepatitis
    Start date: 2012-01-09
    End date: 2012-05-01

Other drugs received by patient: Lexotanil



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient:

Reactions: White Blood Cell Count Decreased, Contusion, Anaemia, Fall, Loss of Consciousness, Haemoglobin Decreased, Anxiety, Dysgeusia, Urine Uric Acid Increased, Disturbance in Attention, Injury, Feeling Abnormal, Asthenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-03-03

Rebetol
    Dosage: unk unk, qam
    Indication: Hepatitis C
    Start date: 2012-03-03

Rebetol
    Dosage: unk unk, qpm

Rebetol
    Dosage: unk unk, qam

Rebetol
    Dosage: unk unk, qpm
    Start date: 2012-03-03

Rebetol
    Dosage: unk unk, qpm

Rebetol
    Dosage: unk unk, qam

Victrelis
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-03-31



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient:

Reactions: Injection Site Erythema, Nasal Dryness, Epistaxis

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-16

Rebetol
    Dosage: unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-07-16

Victrelis
    Dosage: unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-08-20



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-27

Patient:

Reactions: Fatigue, Nausea, Headache

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram, qw

Rebetol
    Administration route: Oral

Other drugs received by patient: Zyrtec; Lisinopril; Nortriptyline HCL; Atenolol; Prilosec; Estradiol



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: Psychiatric Symptom

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-02-21
    End date: 2012-03-16

Rebetol
    Dosage: cumulative dose: 20000 mg
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-21
    End date: 2012-03-13

Rebetol
    Dosage: cumulative dose: 20000 mg
    Administration route: Oral
    Start date: 2012-03-13
    End date: 2012-03-16

Telavic
    Dosage: cumulative dose: 56250 mg
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-21
    End date: 2012-03-16

Other drugs received by patient: Loxoprofen; Allopurinol



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient:

Reactions: Back Pain, Drug Ineffective, Swelling

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-24

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-24

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-08-21



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient:

Reactions: Back Pain

Drug(s) suspected as cause:
PEG-Intron
    Indication: Hepatitis C

Rebetol
    Administration route: Oral
    Indication: Hepatitis C

Victrelis
    Administration route: Oral
    Indication: Hepatitis C



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Anaemia, Rash, Haemolytic Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-31
    End date: 2012-03-16

PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-01-31
    End date: 2012-03-15

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-04-24
    End date: 2012-05-21

Ribavirin
    Dosage: 500 mg, qd
    Administration route: Oral
    Start date: 2012-05-22

Ribavirin
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-03-21
    End date: 2012-04-03

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-31
    End date: 2012-02-27

Ribavirin
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-02-28
    End date: 2012-03-17

Ribavirin
    Dosage: 300 mg, qd
    Administration route: Oral
    Start date: 2012-04-04
    End date: 2012-04-23

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-31
    End date: 2012-03-16

Other drugs received by patient: Coniel; Famotidine; Allopurinol; Celestamine (Betamethasone (+) Dexchlorpheniramine Maleate (+) Fluphen; Isosorbide Dinitrate



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: Pancreatitis Acute, Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-05-11
    End date: 2012-06-15

Rebetol
    Dosage: 800 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-11
    End date: 2012-06-20

Telaprevir
    Dosage: 2250 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-11
    End date: 2012-06-20

Other drugs received by patient: Talion (Bepotastine Besylate); Feburic; Famostagine D; NEO-Minophagen C; Urdeston; Trebianom; Sitagliptin Phosphate



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Rash

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, unk
    Start date: 2012-06-19

Rebetol
    Dosage: 600 mg, unk
    Administration route: Oral
    Start date: 2012-06-19

Rebetol
    Dosage: 400 mg, unk
    Administration route: Oral
    Start date: 2012-07-03

Telavic
    Dosage: 2250 mg, unk
    Administration route: Oral
    Start date: 2012-06-19



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Anaemia, Blood Uric Acid Increased, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 30 microgram per kilogram, qw
    Start date: 2012-07-05

PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-06-14
    End date: 2012-06-21

PEG-Intron
    Dosage: 50 microgram per kilogram, qw
    Start date: 2012-07-12

PEG-Intron
    Dosage: 70 microgram per kilogram, qw
    Start date: 2012-07-19

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-14
    End date: 2012-06-27

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-07-05

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-14
    End date: 2012-06-27

Other drugs received by patient: Theo-DUR; Lendormin; Mucodyne



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-27

Patient:

Reactions: Exposure VIA Father

Drug(s) suspected as cause:
PEG-Intron



Possible PEG-Intron side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient: female

Reactions: Dehydration, Anaemia, Lower Respiratory Tract Inflammation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-02-15

Ribavirin
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-02-15

VX-950
    Dosage: 750 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-15



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient:

Reactions: Myalgia, Injection Site Haemorrhage, Nausea, Chills, Sinus Headache, Hyperhidrosis, Muscle Spasms

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-22

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-22



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: Malaise, Renal Impairment, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, unk
    Indication: Hepatitis C
    Start date: 2012-06-06

Rebetol
    Dosage: 600 mg, unk
    Administration route: Oral
    Start date: 2012-06-15
    End date: 2012-06-20

Rebetol
    Dosage: 200 mg, unk
    Administration route: Oral
    Start date: 2012-06-21
    End date: 2012-07-12

Rebetol
    Dosage: 800 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-06
    End date: 2012-06-14

Rebetol
    Dosage: 200 mg, qod
    Administration route: Oral
    Start date: 2012-07-13

Telavic
    Dosage: 1500 mg, unk
    Administration route: Oral
    Start date: 2012-06-08

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-06
    End date: 2012-06-07

Other drugs received by patient: Lendormin; Lansoprazole; Amoban



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-27

Patient:

Reactions: Gingival Pain, Glossodynia, Stomatitis, LIP Pain

Drug(s) suspected as cause:
PEG-Intron



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Interstitial Lung Disease, Oedema, Hepatic Failure

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bactrim
    Dosage: 1 df, once
    Administration route: Oral
    Indication: Adverse Event
    End date: 2012-06-09

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-03-13
    End date: 2012-04-04

Rebetol
    Dosage: 800 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-13
    End date: 2012-04-04

Telavic
    Dosage: 2250 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-13
    End date: 2012-04-04

Other drugs received by patient: Urso 250; Lasix; Celestamine TAB; NEO-Minophagen C; Aldactone



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: Drug Eruption, Haemoglobin Decreased, Malaise, Hyperglycaemia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-05-17

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-17
    End date: 2012-06-13

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-06-14
    End date: 2012-06-28

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-07-18
    End date: 2012-07-26

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-17
    End date: 2012-05-25

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral

Other drugs received by patient: Motilium; Gasmotin; Diflorasone Diacetate; Nizatidine



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient:

Reactions: Headache

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-16

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-17

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-08-12



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Rash

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-05-07

Rebetol
    Dosage: 200 mg, unk
    Administration route: Oral
    Start date: 2012-06-25
    End date: 2012-07-30

Rebetol
    Dosage: 400 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-07
    End date: 2012-06-24

Telavic
    Dosage: 1500 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-07
    End date: 2012-07-08

Other drugs received by patient: Loxonin; Olopatadine HCL; Allopurinol; Betamethasone Sodium Phosphate



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Anaemia

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-04

PEG-Intron
    Dosage: 1.5 ?g/kg, qw
    Indication: Hepatitis C

Ribavirin
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-02-08

Ribavirin
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    End date: 2012-02-07

Other drugs received by patient: Lorfenamin; Livalo; Epadel S; Claritin Reditabs; Sodium Ferrous Citrate



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014